Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Ethical Issues in Geriatric Psychopharmacologic Research

Ethical Issues in Geriatric Psychopharmacologic Research CHAPTERS Ethical Issues in Geriatric Psychopharmacologic Research J ASON H. T. KARLAWISH & BRYAN J AMES DI VISION OF GERIATRIC MEDICINE, CENTER FOR BIOETl-IICS AND ALZHEIMER'S DISEASE RESEARCH CENTER U NIVERSITY OF P ENNSYLVAN IA INTRODUCTION Th e foc us of this chapter is the ethi cs of research that in volves eld erl y patients w ith neurodcgcnerativc and psychiatric diseases. Society allows geropsyc hiatrk research because it believes that research is among the best ways to improve the s tan dard of care for e ld erly person s w ho ha ve conditions such as anxiety, delefium, dementia, depreSSion, and psy~ chosis. This is scientific progressivism. But thi s progressivism faces two cha!lengcs. First, some geropsyc hi­ at ri c patients are "vulnerab le" because they have relative or even absolute impairments in their abilities to formulate and express their p references and to make ch oices that p ro tect their interests (Lev ine, 1986). Vulnerabil­ ity can be the result of the patients' cognitive or emotional impairm e n ts, or the ir residence in a "total institution" such as a nursing home o r p sy­ chiatric hospital. Like prisons, monasteries, and boa http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annual Review of Gerontology & Geriatrics Springer Publishing

Ethical Issues in Geriatric Psychopharmacologic Research

Loading next page...
 
/lp/springer-publishing/ethical-issues-in-geriatric-psychopharmacologic-research-ZP3jc5i6ox
Publisher
Springer Publishing
ISSN
0198-8794
eISSN
1944-4036
DOI
10.1891/0198-8794.19.1.72
Publisher site
See Article on Publisher Site

Abstract

CHAPTERS Ethical Issues in Geriatric Psychopharmacologic Research J ASON H. T. KARLAWISH & BRYAN J AMES DI VISION OF GERIATRIC MEDICINE, CENTER FOR BIOETl-IICS AND ALZHEIMER'S DISEASE RESEARCH CENTER U NIVERSITY OF P ENNSYLVAN IA INTRODUCTION Th e foc us of this chapter is the ethi cs of research that in volves eld erl y patients w ith neurodcgcnerativc and psychiatric diseases. Society allows geropsyc hiatrk research because it believes that research is among the best ways to improve the s tan dard of care for e ld erly person s w ho ha ve conditions such as anxiety, delefium, dementia, depreSSion, and psy~ chosis. This is scientific progressivism. But thi s progressivism faces two cha!lengcs. First, some geropsyc hi­ at ri c patients are "vulnerab le" because they have relative or even absolute impairments in their abilities to formulate and express their p references and to make ch oices that p ro tect their interests (Lev ine, 1986). Vulnerabil­ ity can be the result of the patients' cognitive or emotional impairm e n ts, or the ir residence in a "total institution" such as a nursing home o r p sy­ chiatric hospital. Like prisons, monasteries, and boa

Journal

Annual Review of Gerontology & GeriatricsSpringer Publishing

Published: Jan 1, 1999

There are no references for this article.